The annual J.P. Morgan Healthcare Conference includes presentations from many major medtech companies outlining their growth strategies and expectations for 2021. Here are some of the highlights from the third day of the meeting.
Although the pandemic has caused many surgeries around the world to be postponed or cancelled, the demand for Intuitive Surgical, Inc.’s market-leading robotic surgical instruments remains strong, CEO Gary Guthart said during his presentation at the J.P. Morgan conference.
“We've had some challenges as it relates to quarantines and COVID in our supply and our manufacturing, and we've had some opportunities to improve quality and those [issues] have had...
The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.
Fujirebio Diagnostics' Alzheimer's disease test, Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, has been cleared by the US FDA.
The consumer genomics firm will operate as a subsidiary, while Regeneron plans to leverage its database for drug discovery and trial design efforts.
